survivor Posted December 17, 2009 Share Posted December 17, 2009 Lurasidone is an atypical antipsychotic for the treatment of schizophrenia and bipolar disorder by Dainippon Sumitomo Pharma. It is currently in Phase III clinical trials. Very low side effect profile! I read somewhere that the drop out rate was almost the same as with a placebo! http://en.wikipedia.org/wiki/Lurasidone Link to comment Share on other sites More sharing options...
This topic is now archived and is closed to further replies.